Radiotherapy for PSA recurrence after radical prostatectomy

被引:27
作者
Vanuytsel, L
Janssens, G
Van Poppel, H
Rijnders, A
Baert, L
机构
[1] Univ Hosp, Dept Radiotherapy, Louvain, Belgium
[2] Univ Hosp, Dept Urol, Louvain, Belgium
关键词
radiotherapy for PSA; radical prostatectomy; prostatic neoplasm; PSA recurrence; salvage radiotherapy;
D O I
10.1159/000052480
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The treatment of patients presenting with an isolated PSA recurrence after radical prostatectomy (RP) remains controversial. The present study aims at assessing the results of salvage radiotherapy (RT), to define prognostic factors and to identify subgroups of patients most suitable for RT with curative intent. Materials and Methods: A retrospective study was performed of 53 patients, diagnosed with a rising PSA after RP, and treated with RT to the prostate bed, between July 1992 and July 1998. Results: On univariate analysis, significant determinants to obtain and maintain a nondetectable PSA (<0.02 ng/ml) were Gleason grade (<less than or equal to>III vs. greater than or equal to IV), pre-RT PSA, considered as categorical or continuous variable, and pathological stage, pT (2 vs. 3). Pre-RP PSA (less than or equal to 10 vs. >10), time interval between surgery and moment of rising PSA and pathological section margin status were not significant. On multivariate analysis, only Gleason grade and pre-RT PSA remained significant. For the patient group with a Gleason grade less than or equal to III the PSA-free survival at 3 years was 75% (+/- 11%) com pared to 27% (+/-9%) for the patients with a Gleason grade greater than or equal to IV (p = 0.002). Pre-RT PSA significantly influenced PSA-free survival in the first group, but not in the latter. Conclusion: From the group of RP patients with rising PSA following a postsurgery PSA-free period, subgroups can be defined with a distinctly different probability of obtaining and maintaining nondetectable PSA levels after salvage RT Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 22 条
[1]   MULTIVARIATE-ANALYSIS OF FACTORS PREDICTING LOCAL RELAPSE AFTER RADICAL PROSTATECTOMY - POSSIBLE INDICATIONS FOR POSTOPERATIVE RADIOTHERAPY [J].
ANSCHER, MS ;
PROSNITZ, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (04) :941-947
[2]   Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy [J].
Lange, PH .
JOURNAL OF UROLOGY, 1998, 159 (01) :177-178
[3]   RADICAL PROSTATECTOMY FOR PATHOLOGICAL STAGE-C PROSTATE-CANCER - INFLUENCE OF PATHOLOGICAL VARIABLES AND ADJUVANT TREATMENT ON DISEASE OUTCOME [J].
CHENG, WS ;
FRYDENBERG, M ;
BERGSTRALH, EJ ;
LARSONKELLER, JJ ;
ZINCKE, H .
UROLOGY, 1993, 42 (03) :283-291
[4]  
Coursey John W., 1999, Journal of Urology, V161, P300
[5]   Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation [J].
Crane, CH ;
Rich, TA ;
Read, PW ;
Sanfilippo, NJ ;
Gillenwater, JY ;
Kelly, MD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (03) :681-686
[6]   An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: Implications on the use of adjuvant therapy [J].
DAmico, AV ;
Whittington, R ;
Malkowicz, SB ;
Loughlin, K ;
Schultz, D ;
Schnall, M ;
Tempany, CM ;
Tomaszewski, JE ;
Renshaw, A ;
Wein, A .
UROLOGY, 1996, 47 (04) :538-547
[7]  
Do T, 1998, CANCER J SCI AM, V4, P324
[8]  
EPSTEIN JI, 1993, UROLOGY, V71, P3528
[9]   Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy [J].
Garg, MK ;
Tekyi-Mensah, S ;
Bolton, S ;
Velasco, J ;
Pontes, E ;
Wood, DP ;
Porter, AT ;
Forman, JD .
UROLOGY, 1998, 51 (06) :998-1002
[10]   EFFECT OF RADIATION-THERAPY AFTER RADICAL PROSTATECTOMY ON SERUM PROSTATE-SPECIFIC ANTIGEN MEASURED BY AN ULTRASENSITIVE ASSAY [J].
HAAB, F ;
MEULEMANS, A ;
BOCCONGIBOD, L ;
DAUGE, MC ;
DELMAS, V ;
HENNEQUIN, C ;
BENBUNAN, D ;
BOCCONGIBOD, L .
UROLOGY, 1995, 45 (06) :1022-1027